| 0000-00-00 |
|
|
|
External link to document |
| 2022-08-05 |
1 |
Order |
; 9,616,180; 9,687,611; 9,775,953;
9,861,757; 10,220,155; 10,335,462; 10,357,616; 10,376,652; and 11,097,063…
infringed two or more of the Ozempic patents. While the patents asserted in each action vary
somewhat…Valsartan) Patent Litig., 437 F. Supp. 3d 1372,
1373 (J.P.M.L. 2020); In re Palbociclib Patent Litig., 396…unique patents, this may be a
temporary distinction. Further, many of the “non-common” patents asserted…West Virginia
action derive from the same patent family as patents asserted in the Delaware actions, and |
External link to document |
| 2023-03-22 |
112 |
ANDA Form |
U.S. Patent No. 9,687,611 expires on 2/27/2027; U.S. Patent Nos. 8,920,383, 9,775,953, 10,220,155, and…U.S.
Patent No. 9,687,611 expires on 2/27/2027; U.S. Patent Nos. 8,920,383, 9,775,953,
10,220,155, and…of Expiration of Patent: U.S. Patent No. 8,114,833 expires on 8/13/2025; U.S. Patent Nos. 8,684,969 and…expire on 1/20/2026; U.S. Patent No. 8,536,122 expires on 3/20/2026; Patent No. RE46,363 expires on 8/…expire on 7/17/2026; U.S. Patent No. 9,457,154 expires on 9/27/2027; U.S. Patent No. 9,132,239 expires on |
External link to document |
| 2023-03-22 |
113 |
Patent/Trademark Report to Commissioner of Patents |
9,616,180; ;9,687,611; 9,775,953; 9,861,757; ;10,220,155; 10,335,462; 10,357,616; ;10,376,652; 11,097,… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,114,833; 8,129,343…Semaglutide) Patent Litigation
5 August 2022
1:22-md-03038
835 Patent - Abbreviated |
External link to document |
| 2023-08-02 |
155 |
Notice of Service |
U.S. Patent Nos. 8,129,343; 8,536,122; 8,114,833; 8,920,383; 9,775,953; 9,457,154; and 10,335,462 filed…Semaglutide) Patent Litigation
5 August 2022
1:22-md-03038
835 Patent - Abbreviated |
External link to document |
